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THE ENDOCRINE RELA TIONSHIP TO MALIGNANT �UMOR GROWTH
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INTRODUCTION AND GENERAL CONSIDERATIONS
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THE ENDOCRINE RELATIONSHIP TO MALIGNANT TUMOR GROWTH
"A high percentage of certain strains of mice die
from cancer of the breast and some women seem to have an
inherited susceptibility to the disease."

(Laeser 1941)

Much of the literature of cancer, the theories and the-ex
perimental work, is as confusing and far reaching in its
scope as the above.

Trends in research are ever changing,

and with each new phase comes a flood of material from
which eventually truth arises.

During the past fifteen
"Still

years the trend concerns the hormonal secretions.

more earnestly do I be�ieve that the study of the whole
field of the Internal Secretions will enable us to detect
and correct morbid tendencies with a degree of success
which has been denied to the older methods.

The microbe-

the seed--has ruled the immediate past; the future is with
the soil, the endocrine glands."

(Williams 1922)

"Since the development of the bacterial theory .of in
fection, there is probably no pathological concept that
has latterly so dominated modern medicipe as the doctrine
of the internal secretions of the ductless glands.

11

(

Gar-

rison· 1922)
The purpose of this author is to determine what re
lationship the endo crine secretions bear to malignant tu
mor growth.

The material offered is derived from signifi-
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cant experimental work obtained from the literature .
original work is offered .

No

The var i ous theories as to

the causation of c ancer--parasitic, irritation of chronic
nature, origin in nuclear aberrations, heredity, and others which enter the field--are not considered.
1935)

(Eggers

Th e question th e writer proposes an d will attempt

to answer is, "Do the hormones cau s e c a ncer? 11

The plan

of this writer is to consider each endocrine s ecretion
and by significant, selected experimen t al material from
the li te rature, show what relationship each hormone has
to t he problem set forth .

Little attempt will be made to

correlate the workin gs of th e endocrine system, this could
truly be a subject in itself.

However, such interrela-

tions of the endocrines will be consider ed only insofar
as they influenc e malignant tumo r g rowth--if th is influence be present.

It s eem s de sirable to first consider

the endocrine secretions as a whole subject, and from
this point make a more specific study o f ea ch hormone .
Some fifty years ago Brown, Sequ a rd, a n d d'Arsonval (Williams 192 2) talked of the maintainance of the normal body with reference to cellular secretions.

The the-

ory read that each tissue and each cell secreted certain
produc t s o r special ferments which influenced all the
cells of the body, a definite solidarity being thus estab-
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lished among a ll cells through a mechanism other than
the nervous system.

All the tissues (glands and other

organs) have such secretions, other than waste, which is
given to the blood.

The internal secretions whether by

direct favorable influ ence or by hindran ces to deleterious process seem to be of great utility in maintaining
the organism in its normal state.

A normal harmonious

interaction between cells, tissues, organs, and parts of
the body was proposed.
enzyme s.

Th e secretions mentioned were not

Their effect was to be specific for certain types

of cells, and their mode of action through permeability
of the lipoid material a bout cells, or effective through
a combin a tion with cells and effect upon metabolism .

One

might add that the mechanism of hormonal action as determined by present day experimentation is little understood
(Smi t h , Wells, and d'Amaur 1942).

However, their func-

tion is well established .
The work of Smit h , Wells, and d'Amaur (1942), wil l
serve as an introduction to th~ large question to be answered .

It is an exploratory study of a large number of

experiments, not a thorough study of one treatment .

A

number of endocrines are known . to influence metabolism '
while other hormones are conce r n e d in genital and somatic
growth.

It is therefore p r opo sed that abnormalities of
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✓

of metabo lism and growth wh ich charac terize tumor growth
might be due to or infl uenced by derangements in such
hormones~

Co mpa rabl e results would not be valid for dif-

ferent strains of experimental animals .
true of differently induced tumors .

Nor would it be

For this reason the

work e rs selected the same strain of mice, and the tumors
wer e produc ~d by chemical methods .

The method of experi-

ment a tion was the investigation of both an increase and a
decrease of secretions.

No combinations were used.

The de-

cre ased supply of a secretion was produ ced by partial extirpation of the various glands .

The carcinogen used was

methylcholanthren, which produces 100 pe rcent in the Denver
strain mice .

It has a short latent period.

Because it is

thought that the estrin group has a greater effect on slow
growing tumors, 1, 2, 5 , 6 dibenzanthracene was used in the
hyperestrin group .

Denver strain mice, wh ich have a zero

incidence of spontaneous tumors, were selected--these were
six weeks old and developed through ten years of inbreeding .
A subcutane ous inj e ction of one-fifth of a cubic centimeter
of the carcinogen was mad e bet ~een the shoulders, at each
hip , an d. at th e mam,.iary 1 ine on each side of the abdomen.
At the time of injection of th e ca r cinogen endocrine administratio,. was begun .
vid e d as follm,·,s :

The experi me ntal gr oups are di-
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I.
II.

III.

IV.

V.

VI.

Control (Pro duction of tumor by methylcholanthrene
in paraffin. A short latent pe riod is not ed).
Gonadal hormones
a. Hyper-estrin (estradiol of benzoata).
b. Hyper-pro gestin (Progestin in oil).
c. Hypo-estrin (Ovariectomized ten days previous to tumor production).
d . Hyper- testosterone (Testosterone propionate)•.
e . Hypo-testosterone (Cas tration ten days
previous to induction of carcinogen).
Gonadotropic hormones
a. Pr egnant mar e serum (Gonadin--high and
low doses).
b. Pregnan cy urine (Koro t in--high and low
doses).
Adrenal hormones
a . Hyper-cortin (Adrenal cortex extract) .
b . Hyper-de soxycorticosterone
c. Hypo-cortin (Adrenals removed one week
after injection of carcinogen. That amount necessary for life was supplied).
d. Hyper-adre nalin (Adrenalin in oil).
e. Hypo-adrenalin (Medulla removed through a
slit in the cortex).
Thyroid and Pancreas
a. Hyper-thyroid (Thyroxyl given until extre me thyrotoxicosis reached)!
b. Hypo-thyroid (Thy roidectomy one week after
injection of carcinogen).
.
c. Hyper-insulin (A constant hypoglycemia
maintained).
a. Hypo-insulin (Pancreas removed one week
aft er carcinogen given) . ·
Pituitary hormones
a . Hyper-pi tuitary (Fresh sheep pituitary).
b. Hyper- growth hormone (phyone--anterior
lobe hormone) .
c. Hyper-prolactin (prolactin).
d. Hypo-pituitary (re moval).
Tumo rs we re measured by the PAlpation method, and a

mass one centimeter in volume designated as that which
was to be considered.

The rate of growth was determined

in the control grou p and the mean latent period derived
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from th e l ength of time n e c Assery to produce the on
c e ntimeter tumor mass - -this value was d e signated "z e ro" .
The critical ratio was th e n d@tsrminod g iving the vari ous d@ viations of the e ndocrine treated mic"" .
We lls and Smith conclude that no g reat signifi c i:ince
Mas r ea ched in the r esults .

Neither an incr ~R se nor a

decrease of sny hormone p roduc ed a grsat d a viation from

the normal , a lt h ough statistical significant differenc ~s in tho direction of increa sed rat ~ of g ro wth wer
shown by all g roups treated with gonado t ropins .

The hy -

p e rcortin g roup showod diff ere nc e s in the d e crea s ed rat
of g rowth , but no great stress is placed hBre .

Thyroid

xtract has a long carry- over from on e inj e ction to the
next , and the effect was considered nil .
The g onad otropi cs produce gro wt h of the accessory
sex structur$s .

If t he responsiveness of c e ll s forming

the accessory structures in an inherent prope rty of thes
c ~lls , it is p ossiblQ that t umor c al l s , pe culi a rly susceptible to some unknown growth stirrulating f pcto r , mi ght also
b e r~s po nsive .

The high i ncidence of c a rcinoma of th

pros t ate , uterus, and breast mus t not b e overlooked in
t1is respect .

The influence of t h~ ad r e nal medulla,thy-

r oid and pancreas on gtime ral tcmd C8rbohydrate m"tabolism
indicates their possible i mp ort anc~ .
p ituitary and ad r ena l cort e x with l arg
nd int~r -

F inally, th i anter ior

numbe rs of hormones
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relationships give~ wide prospe cts to either an increase
or a decrease of their secretions .
Since methylcholanthrene is 100 percent tumor pr oducin g in mice, the authors believe a possibility exists
that t oo great an effect is produced to be effected by
hormones -- a border line dose of the carcinogen is perhaps the solution .
Do tne hormones effect cells grown in vitro ?

Von

Hamm and Cappel (1940), experimented to answer this qu e stion in attempting to find the endocrine e ffect on tumor
growth .

Pu r e hormones were used, and as the attempt to

fin l opti mum dilutions was fo remost, empirical dilutions
wer e made .

Gr owth was determin e d by the mitotic index

of cells and the increase of surface area .

The cells

used were-fibroblasts grown in tyrodes solution .
Thyroxin was found to be moderately stimulating to
the growth of fibroblasts in vitro in concent r ations of
5
10- , higher concentrations retarded growth .
Insulin increased the growth of the cells some ten
times , but this is explained by the large amount of fat
droplets formed, the mitotic index being little changed .
In all dilutions adrenalin was inhibi t ory to g rowth .
A lo w mitotic index was found - -lowes t

in the higher c on-

8

centrations .
Cortin gave the same results as adrenAlin .
The greatest surface area increase of the fibro blasts occurred du ring the second to fourth day when estrin was used.

The mitotic index was slightly higher

than the tyrode solution control.
Testosterone and proges~in were found to be inhibitory to cellular growth .

Testosterone showed the lowest

surfa ce area increase, while progestin gave the lowest
mitotic index .
The authors conclude tha t as far as the endocrine
effect on the growth of fibroblasts is concerned, the hor,

mones examined could no t. be regarded as significant growth
-sti mulating agents.
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THE PITUITARY
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In the work thus far presented one sees little indication t hat any of the hormones are influencing to malignant tumor growth .

Certainly this is not representive

of this field of canc er research .

Ho wev e r, there is a

mere suggestion t h at cancer production is tied up with
physiologic activity .

(Cramer 19 40)

With this in mind

one·· certainl y se e s the necessity for more specific study
of each endocrine gland, and any ana l y sis of the trends
in cancer research must be a correlation of e a ch advance
made .

(Murphy 1938)

Cramer discusses the origin of can-

cer in ma~ in his recent publication (1940) .

He believes

cancer production by the endocrine s involves two variables--susceptibility and the carcinogenic agent .
stant factor is present .

A con-

One variable increases as the

other decriases, th e refore cancer ma~ arise with a high
susceptibilit y a nd a low c a rcino gen ic stimulus .
seems to be another variabl e .

Time

Ca n cer may arise in a

y oung indivi dua l wit h a high suscepti bility and stimulus.

He s hows tha t different strains of mice produc e

the same amounts of estrogenic substance, but one strain
may be more susceptibl e .

The endocrines, however, are

interrelated, as the estrogens are related synergisti call y to the hormones from the adrenal cortex, and antagonistically to the hormones fro m the anterior pituitary .
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Imbalanc e of any of these hormones could then alter the
astrogen su pply .

It is conceived that changing the phy-

siologic action of the endocrine secretions may produce
cancer .
The physiologic properties of the anterior lobe of
the pituitary are numerous a n d well known .

Do the secre-

tions have any effect on malignant tumor growth?

Robert-

son Burnet t (1916) isolated tethelin, the growth controlling principle, and other alcoholic extractives fro m
the anteri or lob e of t he pituitary.

Th e action on mor-

mal rat growth was th e retardation of early growth in
weight and acceleration ~f post-adolescent growth.

Their

experiment consisted of producing the Flexner-Jobling
c a rcinoma in r ats by inj e ction of tumor substance into the
axillary region, w~ich gave 60 to 90 percent successful
transfer .

Of the 73 rats used in the experiment, 49 had

well developed tumors in 21 days.

Twenty-four rats served

as the control group, while 25 received injections of
tethelin 21, 23, 25, 28, and 30 and 32 days following tumor induction.

The average dose of tethelin was equal

to abou t three anterior pituitary lobes of the rats.
results are tabulated as follows :

The
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DAYS AFTER I N\T OCULATION

SIZE OF TUi'l10RS IN MILLIMETERS
CONTROL

21
23
25
28
30
32
35

WITH TETHELIN

100
105 . 6
111.5
122 . 6
130.6
143 . 5
154 . 9

100
117 . 4
126 . 4
147 . 6
156 . 2
167.0
176.0

A mark ed acceleration is noted in r ate of growth of
tumors, some two or three times as rapid as the control
tumors.

At 63 days the animals we re killed and autop-

sie d t o judge metastatic gr owth .

Nine percent of t he

control animals, and 35 percent of the tethelin treated
animals showed metastatic tumor growths .

The conclusions

the authors draw from the experiment are noteworthy :

(1)

tethelin markedly increases the rate of prima ry and metastatic tumor growth (2) the other alcoholic extractives
of the ant erior lobe have no effect, with the exception
of lecit h in (3) the lecithin fraction causes a decrease
in tne gro wth r ate of tumors .
The author fee ls t h e work done b i Robertson and Burnett prior to 191 6 best s ubstantiates the experi ment just
prese nted (Robertson and Burnett 1915) .

A preparation

of an terio r lob e pitui ta r y ~as used to determine the effec t of growt h of the Fl e xne r-Jobling c arcinoma in r a ts.
Innoculatio n -gave 60 to 90 perce nt carcinoma production
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in the axillary region.

Twenty-eight rats with carcin-

oma were used, with 14 constituting the control group.
When the pituitary extract was injected directly into
the produced tumor the following results were obtained:

DAYS AFTER I NNOCULATION DIAMETER OF TUMORS IN MILLIMETERS
CONTROL

PITUITARY TREATED

100
109
119

22

25
28
30

100

113
137
160
178
178
184

134

32

139

34

154
152

37

The animals were killed 37 days following innoculation
and metastasis st u died.

Twenty-one percent of the con-

trols developed metastasis , but none of the pituitary
treated animals showed suc h growth .
100
80

PERCENT INCREASE
60

OVER THE DIAMETER
40

AT 22 DAYS
20
0

22

24

26

28

30

32

35

DAYS AFTER INNOCULATION
THE COMPARATIVE GROWTH OF UNTREATED TUiJIORS AND TUMORS
TREATED WITH PITUITARY EbiULSION
ighteen rats with tumors were the n innoculated with

36
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pituitary extract on the opposite side of the body .

Of

these animals 89 percent developed tumors, and.each was
given an injection of pituitary extract 7, 9, 11 , 14 ,
16, and 19 days following tumor induction.

No marked ac-

celera tion of tumor growth was noted during this period .
-

Tumor was then produced in 34 rats and allowed to grow
untreated with pituitary extract until 21 days after production .

At 21 , 23, 25, and 28 days following tumor in-

duction, 17 of these rats received injection of pituitary
e mulsion, while 17 we r e used as controls .

The outcome

of the completed ex periment showed the first control
group- -up to 21 days- - to hav e tumors 16 . 4 millimeters in
diameter, and the treated -ani mals at 21 days to have tumors 17 . 9 millimeters in diameter .

All rats treated with

pituitary extract after 21 days showed a marked increase
rate of tumor growth .
50
P1TU1TAR.Y

40
PERCENT INCREASE

30
OVE R THE DIAI\:ETER

20
AT 21 DAYS

lll'Jld

10

21

22

~~

24

25 ·25

27

28

29

DAYS AFTER I NNOCULAT IOl'r
COMPARATIVE GROWTH OF UNTREATED TUMORS

D Oi< TUMORS

TREATED WIT H PITUITARY EMULSION BEFORE AND AFTER 20 DAYS

FOLLOWING INNOCULATION

30
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"Th e pituitary extracts of the anterior lobe increase the rate of malignant tu .H or growth in rats, but
only after 20 days follo~ing induction of the tumors is
this evidenced.
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Tumor in duction and tumor grorth have been studied
in hypophysectomized mi ce (Korte weg and Thomas 1939) .
The study consist ed o f extensive experimentation on 250
mice in wh ich th e Jansen sarcoma was produced .

The au -

thors noted that if hypophysectomy was p~rformed in the
tum or carrier the sarcoma grew much slower than in the
control animals- - gr owth was found to stop or re gress in
some instances.

If grafting of the sa rcoma was the ex-

perimental procedure, the tumor reached a size of one to
one and one- half centimeter s and then in many cases growth
I

regressed .

Another procedure o f fer ed gro~th hormone to

the hypophysect~mized animals which contained the tumor,
the sarcoma continued to brow as in the control series .
Re gression of tumor growth could be ha stened by supplyin g folliculin to the mice .

And lastl y , exti rp~ti on of

the posterio r or middle lobes of the p ituit a ry of mice
had no apparent effect on tne rate of sarcoma growth .
Korteweg and Thomas (1939) also transplanted carcinoma from the bre asts of mic e to 31 hypophysectomized
animals .

These tumors grew .

In 13 of the mice the hy -
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pophysis was extirpated six months before the transplants
were added so t hat no postoperative hormonal effect wou l d
b e evident .

There was no noted growth difference either

grossly or microscopically bet we en th e hypophysectomized
animals and the normal control group .

An equal number

of mitotic figures was noted in each instance .
Tumors induced with 3, 4 benz pyrene will grow in the
control and hypophysectomized mice, but growth in the
latter case is markedly retarded .
The function of the pituitary seems inhibited by
estrin .

(Sokoloff and Arons 1940)

When mice are in-

jected with estrin the males show an increase in the size
of the gland, fe males may develop hypophyseal tumors .
Cancer implants cau se increase in the number of acidophil
cells, not unlike th e injection of estri n .

In malignant

conditions t he pituitary increases in function, according to Sokolo f f an d Aron, and t h e basophil cells increase
in number .
e stri n .

This reaction is th e reverse of injection of

Gonadectomy al so l eads t·o the hypertrophy of

the gland with an increase in the basophil cells .
Zondels (1939) found that estrogenic substances supplied to a rat enlarged the pituitary (normal ten milligrams) two times normal size in a four month treatment .
Continued estrogenic treatment for eight months lead~ to
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pituitary hypertrophy of 149 . 3 milli gra ms .
trophy was thought to be chromophil

The hyper-

cells .

Further discussion of the pituitary body consists
of its relationship to other hormones and their interrelationship to mali gnant tumor growth .

This considera-

tion then is left to be discussed with these specific
hormones .
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HORMONES OF THE THYRO I D, PARATHYROID, A.cm ADRENAL GLANDS

{
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The thyroid, adrenal , and parathyroid hormones are
considered together as one group .

The material concern-

in g the specific effect on malignant tumor growth is very
limited.

Volumes may be read on "Me tabolism of the Thy-

roid" , IIParathyroi d and Calcium Met oboli sm", and "Adrenal
Insufficiency", but it is difficult to find material which
will a i d to an sw er 1he problem on hand .
The thyroid effects tne functions of other endocrines
(Go o dman and Gillman 1940) .

It is responsible for the

normal involution of the thymus; increased activity leads
to increased calcium excretion and parathyroid hypertrophy; the gonads and carbohydrate metabol i sm are affected~
Hamm and Coppel have shown that in vitro thyroxin is
moder a tely stimulating to fibroblastic cellular growth .
Smith, Wells, and d'Amour have shown it has little or no
effect on induced cancer of mice .
11

It is s a id that in Switzerland where goiter is

prevelant, the incidence of cancer is higher than in the
South of Europe" (Benedict 1935) . Goiter producing diets
were given mice in order to determine the rate of induced
tu mor growth .

This result ed in a slow growth of tumors

regardless of the iodine cont ent of the diet .

Poor health

and the diet of the animals was probably the factor in
obtainin g the result rather than any effect of iodine.
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Hamm and Ca ppel found adrenal hormones (cortin and
adrenalin) tote inhibitory in all dilutions to growth
of fibroblasts in vitro .

Smith, Wells, and d'Amour have

sho wn hyper-cortin solution to be inhibiting to induced
mouse cancer .

According to Cramer (1939), the adrenal

is significant, throu gh its relationship with the ovary,
in production of mammary carcinoma in mice .
ship with other hormones is broadly shown .

The relationEstrogens

given to mice will produce hypertrophy of the islands of
Langerhans, a nd the anterior lobe of the pituitary .

Thy-

roid gives an opposite effect--a resting condition of
the above mentioned glands, and brown degeneration of the
adrenal gland .

All the above changes are to take place

before canc er of the breast actually develops.

Brown de-

ge neration of the adrenals takes pl a ce in mammary carcinoma in mice in a high percent of cases .

The effect of

estro gens in adrenalectomized ra ts is greatly decreased .
Estrogen supplied will atrophy the thymus gland , but in
the adrenalectomized animal the thymus continues to grow
or persists.

Estrogens tend to enlarge the breasts by

cellular hypertrophy, but in adrenalectomized mice the
breasts show no glandular activity .

As a summary then,

adrenalectomy makes mice resistant to the physiolo g ic effect of the estrogens, mammary secretory activity is ar-
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rested or decreased, and the carcinogenic activity of the
estrogens is weakened .

By this method the adrenal gland

see ms to play a part in mammary c ar cinoma in mice .
Studies made on the parathyroid glands and serum
calcium, and the effect on the growth of Flexner rat carci nema may be significant :

FLEXNER CARCINOMA IN

RA" ·

WEIGHT OF TUIVIOR I N GRAMS
5 . 25
13 . 59
17 . 63
6 . 58
12 . 70
24 . 10
75 . 41

(Goerne r and Shofiroff 1928) .

RECE I VING PARATHYROID HORMONE
TISSUE CALCIUM
4. 2
8.6
9.4
4.0
6. 4
14 . 7
18 . 2

FLEXNER CARCINOMA--CONTROL GROUP
WEIGHT OF TUMOR IN GRAMS
5 . 40
8 . 32
3 . 50
13.52
10 . 46

TISSUE CALCIUM
4.8
5. 3
3.0
8.2
5. 8

Parathyroid hormone causes an increase o f tumor
growth a nd increased calcium in t he tis sues .

22

THE

SEX

HORMONES
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The major ity of work in co nsideration of endocrine
c arcinogenesis is found to deal with the sex hormones, and
of course their interrelationship to the endocrine system .

Duplication of experimental procedures is a promi-

nent feature fo un d in t he litera ture.

~e cause of this

the author intends to present a selective group of experiments, which in turn wil l attempt to demonstrate the
effect played by this group of endocrine secretions on
the various organs.
Cramer (194,m s hows that s ubstances physiologic to
the body play a pa~t in carcino genesis.

The estrogens,

for example, effect tumor growth by a property of their
phy siolo gic activity.

The high incidence of cancer of

the uterus , mammary glands, and prostate- -o rgans not subject to outside influences--cert ainl y suggests an endocrine basis.

H~ states the effect is of long duration,

during which time a definite pathologic change, hyperplasia, takes pl a ce--this precancerous condition is then
followed by the mature form .
It has been shown previously by Wells, Smith, and
d'Amour (1942) that the gonadotropic hormones were the
consistent factors in their series of experiments .

As

far as fibroblasts are concerned, Ha mm and Cappel (1940)
s howed the sex hormones to have little effect as growth
stimulating hormones .

Hormonal relations have be en shown

24

between the ovary and adrenal glands (Cramer 1939) .
The work of Loeb (1935) is considered significant .
The sex cycle is reviewed showing a number of hormones
to be involved .

The follicular and luteal hormones be-

ing well known.

It has long be en

known that coal tar

products are capable of producing carcinoma in mice .
close relationship between

the

A

sterols and some of the

sex hormones was est a blished by Aschheim and Hohlweg,
according to Loeb.

Coal, it is found, has estrogenic

properties in mice, rats an d ca pons--in fact, estrus may
be produced in rats and a change in plumage noted in capons with the administration of coal .

Significant is the

fact that the est rogens will produce active cellular
proliferation , in other words, are related to hydrocarbon
care inogenesi s .

11

Ac ti ve carcinogenic hydrocarbons are

also estrogenic in nature . "
The most efficient estrogenic compounds is 9:10 dihydroxy 9 : 10 dipropyl 9:10 dihydro 1: 2 :5~6 dibenzonthracene .
Of interest is the fact that the two most active carcinogenic hydrocarbons, l:_2 benzpyrene and 5~6 cyclopenteno
1:2 benzanthracene are a lso estrogenic in nature .

By a

co mpa rison of the two groups of compounds--some carcinogenic compounds are estrogenic; likewise , some estrogens
are not carcino ge nic, some carcinogenic compounds are

25

not estrogenic.

There is no parallelism between the

strength of these activities--the mo st potent ~arcinogens are no t the most potent estrogens .
then, Loeb states :

As a summary,

the hydrocarbons of tar and estro-

genic substances may induce c ar cinoma.

Estrogens are

limited to only the tissues they effect during the normal
sex cycle.

The effects of estrogen appear to be multiple
1936).

(a ~~~~~~

Of 679 mice investigated, only one received es-

trogen, and only this mouse was found to have a pituitary tumor--hyperplasia of the chromophob e cells of the
anterior lobe.

Associated chan 6es which were attributed

to the injection of estrogen include:

adeno ma of the

thyroid, adrenal change s--muc h fat present and round
masses of cytoplasm characterized th e cells, and extensive development of the mammary acini much like the changes
found in t he pregnant b r east dur ing secretory and lactogen ic activity.

The testis we re not effected .

Experimental signific ant evidence of the effect of
theelin and estradiol on malignant tumor growth is offered by Bischoff , Long, Rupp, and Clarke (1942).

The

growth of lymphosarcoma and adenocarcinoma was observed
in March-Buffalo mice under the influence of sesame oil
which served as the control, and under the influence of
estradiol and theelin in both ovariectomized and ovaryintact mice .

Treatment was necessarily over a long period
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of time in order to produce any noted effect (two injections of estradiol each/ week for six months).

Of the

four groups of 40 mice, thirteen percent of the control
group died, 22 percent of the estradiol-dosed group died,
35 percent

with theelin, and 20 percent of the ovari-

ectomized and estradiol-dosed died during a seven month
treatment.

The authors admit the perversion of the ex-

perimental results where the de ath rat e reached high proportions before t he desired effect was determined .

How-

ever, in some cases the results are of sufficient magnitude to warrant evidence of their effect .

Estradiol in-

creased the growth of lymphosarcoma in both the intact
and ovariectomized animals, 27 percent increase over the
control group in the former case, and 47 percent in the
latter .

Theelin effect s hows a doubtful value--15 per-

cent over the control animals .

Concerning the growth of

adenocarcinoma, a slight increase is noted in the theelin
dosed a n i mals, but insignificant values are given estradiol treated and ovariectomized- estradiol treated mice .

To

summarize:

Th e incidence of lymphosarcoma in Marsh-

Buffalo mice is definitely increased by estradiol .
si gnificance of theelin is doub t ful .

The

The increase of the

incidence of adenocarcinoma is given little value .

If

the evidence is based on th e remaining mice and not cumu-
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lative evidence, theelin shows an effect towards increas ing the incidence .
Gardner (1939) produced the entire sequence of uterine, vagiral, and mammary changes in ovariectomized mice
by ovarian estrogenic and luteal hormones .

Remova l of

the ovaries at three to five months inhibited or greatly
delayed malignant tumor growth .

No change in growth wa s

noted if the ovaries were re moved from eight and onehalf to ten months .

Male mice, of a strain with a zero

incidence of spontaneous tumor growth , when subjected to
ovarian grafts showed a seven
nant tumors .

percent incidence of malig-

Lo eb (1935) found no relationship between

the regularity and length of the estrus cycle i n the various strains of mice.
Xa le mice also show an interesting response to estrogen ic substances (Gardner 1939) .

The long continued in-

jection of e strogen brings fort h ma li gnant growth --but
onl y in the ma.nmary glands .

These substances appear to

have a marked sti mu latin g effect on the f ibro muscular
tissu es of the se minal vesicles, prostate, and parts of
the urethra .
Gardner also notes the effect of est ro gens on lymphoid and connective tissue tumor s.

The hydrocarbons

will produce carcinoma of the skin when applied directly ,
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but the estrogens fail in this pro pe r ty ~ Spindle cell
sarcoma did develop at sites of injection but this is not
a sp ecific response as liver extract and progestin bring
on the same change .

Leo kemia and lymphosarcoma wer e

foun o i n thre e of 111 mic e receiving estrogenic injec tions .

Tnis relationshi p may be of importance when one

learns tha t l ympn oi d tumors in th is g iv en strain of mice
are rare .

Haa gen sen and Ra ndall (1942) believe that

spindle cell sarcoma and lymphosarco ma are not a specific
response to estrogen ic compounds .

Lacassagne reported

a case of thymic tumor in a mouse receiving estrogen (1939).
The incidence of uterine tumors is low in mice .

Car-

cinoma of the cervix is rare due to the absence of glands
in this region .

It is therefore deduced that any increase

in malignant conditions is due to the hormone offered
(Gardner 1939).

Also no evidence of intrinsic or heredi -

tary factors is present .

The capacit y of estrogen to in-

tensify the squamous character of epithelium of the vagina and cervix is wel l known , often the whole process
gives the rese ~blance of early ca rcinoma .

owever , ir-

regularity and mitosis is not found to a ~reat degree .
Loeb and his associates (1935) found such changes in 10.7
percent of 234 mice , the changes were not considered to
be carcinoma .
lial l esi ons."

Gardner refers to such changes in "epi the He sectioned a11 cervices and uter i of
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estrogen treated ~ice finding no fu ll y developed epitheliomata present-- yet he states that like the mamma,
the uterus responds to estrogens, eventually giving rise
to carcinoma.

Gross carcinoma of the cervix has been

reported in the mouse and attributed to estrogenic stimulation.

Gardner, Strong, Allen and Smith (1938), report

19 "epit helial lesions" i n 100 estrogen treated mice.
Interesting is the fact th a t of 39,000 untreated mice,
22 tumors of the cervix and uterus were noted--hone were
carcinoma.

These authors state that carcinoma of the

cervix is caused in mice by the long continued action of
estrogen.

To support their viewpoint, one large c a rcin-

oma of the cerv ix is reported which is to be convincing
of the estrogen- c a rcinogenic relationship, and that the
other l e sions described in the cervi x are precancerous
lesions.

Estradiol benzoate was given a mouse every three

weeks from 45 until 266 days of age .

A mammary tumoi

developed at this time and was removed.

An other mammary

tumor developed 24 days later and was removed.

The in-

jections of the hormone were now repeated to 359 days at
which time a marked increase of the size of the pelvis
was noted .

Five days later the tumor protruded from the

v ag in a an d the mouse was killed .

The mass was found to

extend from the ut erine horns to the vaginal opening .
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It n ear l y filled the pe lvis and surrounded the rectu m.
Th e ce r v ix co uld sc~r ce l ) b e recognized an C the vag in a
was d enuded .

Th e surround ing lym ph glands were a bnor mal ly

l arge i n s ize .

Microscopically, the p ict ure was that of

a s quam ou s cell carcinoma--the cells in cords or in
irre gu lar ma s s es .

dense

Infil t r a ti on of the r ec t um an d blad-

der musc ulature wa s noted a lon g with metastatic growth
to the surrounding l ymph glands .
11

Estro gen ic hormones e vidently induce the deve l op-

ment of c ancer i n thos e orga ns in which th ey call forth
lon g continued o r of te n repeated growth processes . 11

( Loeb

1938 )

What effect Co t ne sex hor mone s ha ve on mammary c a rcinoma ?

I t was found th a t mammary adenoca r cinoma could

b e re adi l y produ ced in rats by estro ge n s, suc h a lesion
is rare i n unt re ated r ats .

(Kort eweg and Th oma s 1939)

Lac assagne (1939) opened th e f i c l6 for a vast a mount of
work concerning carcinoma of the breast when such malignant lesions were produced by inj e c t ion o f mice with est r on e benzoat e .

Some o f this work concerning t h e effect

of estri n has previously been

presented .

The pituitary

is neces s a r y f or normal mammary gland develo pme nt .

Estrin

gi ven with the pituitary removed results in the failure of
the usual changes produc ed by estrin-- the ma mma undergo
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involution.

Transplantation of the pituitary in turn

leads to the normal response when es ~rin is administered .
Estrin has an inhibitory ac~ion on the pituitary body,
although physiologic hypertrophy of the anterior lobe
basophil and chromophobe cells at first results , hypopituitary function takes place .

"The pitui t ary acts as

an antagonist of tl1e carcinogenic effect of estrin .

11

Testosterone, Lacassagne found, produced several
cnanges in mice .

The estrus c yc le is surpressed.

In the

/

ovarie s corpus lute a are n ot found and the fo llicles fail
to develop .

The mamma ry glands of the female mouse are

reduced to primary ducts--l ike in the male mouse .
pituitary is reduced in size .

The

Testosterone may p la ¥ a

paft i n reducing ma li gnant g ro wth incidence .

Mice which

normall y have a 95 percent incidence of mammary carcin oma
are compared-~20 used as controls all developed carcinoma of the bre ast in

11 months , while 20 mice treated with

testosterone showed only a 35 percent incide n ce in 11
mont h s .
From the wor K of Lacassa~ne it is known that estrogen will pr oduce ca r cinoma of the mamma of male mice .
The plan· of experimentation by Haagensen an d Randal l (1942)
was to dete rmine whethe r estrogens produced carcinoma in
fe ma l e mice , and if so, wha~ histologic changes resulted.
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One dose of estrogen each we e k was injected . . When a
mammary tu mor was a pp a rent , or the mouse died f ro m prolonged treatment the animal was studied at autopsy to
deter mine the effect .

Th e earliest spon tane ous breast

c ar cinoma developed at six months-- animals younger than
t q is were not used .

The control g roups consisted of both

h i gh and low cancer st r ain female and male mice .

The

breasts of the male have little or no epithelial tissue ,
and few d u cts are noted .

However , the breasts of females

are found to have abundan t ducts lined with l ow c uboidal
epithelium .

Bu dding of the d ucts is an important diag-

nostic fin d in g for carcinoma of the breasts of mice , a
transition to carcinoma is observed in the buds .

F i elds

of prolif e rating acini are also seen .
The estrogen effect on the male breast is marked .
Th e entire organ b eco me s jammed wit h closely p a cked cells -there is a great increase o f the epithelial elements .
Mitosis is marked and th e a cini cel l s show an increase
vi g or of growth .

In the high cancer s train mi ce where

the effect is best noted, such develo pment has al l the
ch a racteristics of carcinoma .
The fe ma le breast due to the effect of estrogen s hows
a gross enlargement .

Intens e stimulation is noted by the

proliferation of a ll glandular elements .
of a ll sizes .

Ducts are seen

Budding acini and small solid areas of cel l s
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represent early ca r cinoma.

The ce l ls lining the acini

often betray their malignant tendency by their increased
size, hyperchromatism , mitosis , and irregular ar ran gement
in two layers .
The experiment considered the study of 1 , 526 mice .
· In summary the authors state :

(1) estrogen increases

the inci denc e of mammary carcinoma in mal e mice of a high
c a n cer strain-- 84 .5 pe r cent ( 2) the hormone f~ils to increase the incidence o f female brea st carcinoma (3) estro gen fails to p roduce a note d effect in low cancer
strain mice (4) the histologic evidence of estrogen stimtilation i n breasts of t r,e high and low cancer strains para llels th e effects on tumor incidence .
Vo n Gulik and Korteweg (1 940 ) find supporting ev idence to the work· of Haarensen and Randa l l .

The suscepti-

bility to follicular hor mone and the disposition to mammary cancer was determined 437 spayed female mice of
different genetic composition . · Two high and three low
cancer stra ins were used .

Great differences were found

in the different strain s. , The s u scept ibility to follicul a r hoi mone was less in the t wo high strains tha n in
th e three low st ra ins .

"It is proba bl e that those whose

or gans are less s u sce p tible prod -:.:; c e more es t rogens ."
a result i t is s ugl es~e d th ~t there may exist a causal

As
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relation between the degree of susceptibility of the geni tal organs to follicular hormone a nd the degree of disposition to carcinoma of the mammary gland .
Testosterone and pro 5 estin a re considered in mammary carcinoma (Gardner 1939) .

Hypertrophy of the gland s

is noted with the use of test ost erone .
mice will often

develop carcinoma .

High cancer strain

It does not appear

to i nhibit the development of s pontaneous tumors in females
nor of tumors arising in ma les receiving estrogens .
(This is a contra diction to th e work of Lacassagne ).

Pro-

gesterone produces a slight breast hypertrophy but no ef f e ct is not e d on carci :1ogenesis, according to Gardner .
A great a mount of work has been done in consideration
of the ef feet ~f tne sex ho rm ones on the prost a te gland .
Mu ch of this work consists of ma terial beyond the scope
of this paper--t he consi de ratio n of benign lesions of the
prostate .

The experimentat revie w here , although seem-

ingl ) brief, t h is author consi d ers represe ntati ve.
Prostatic tis s ue is greatl y effected by the hormones .
Estrin increases, whil e the androgens and pituitary decrease the size of the prostate (Hu ggins a nd Clark 1939) .
In experimental animals injection of e strogen produces
carcino ma of

the prostate , (Owen a nd Cutler 1936) .

But

in such a conditi on of the organ the estrogen supply of
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the urine is not notably increased over the normal values .
If the estrogens have an effect it is one of mild stimulation for a long duration of time .
All types of adult prostatic epithelium undergo atrophy with an increase of androg~nic hormones (Huggins ,
Stevens, and Hodges 1940) ~

In . many instances a malig-

nant prostatic tumor is an overgrowth of adult epithelial
cells.

This fact is well s uppo rte d by studies of urine

ph osphatas e .

Phospl. otase is a produ ct of adult cells .

Its value is high . in the adu lt prost ~t e an d low in childh ood and puberty.
studi e s .

Adul t c e lls are made known by such

If in carcinoma of the prostate the phosphatase

l e vel is high, it is well conceived the condition is one
of adult cellular growth.

In eight cases studied Huggins

found the malignant cells high in acid phosphatase.

The

norm a l and hype rtrophied prostate have the same amounts
as found in malignant conditions, th e more infantile glands,
however, sho w low values .
There is no apparent correlation between the number
of interstitial cells of the testis and carcinoma of the
p rostate.

An increase of urinary estrogens or andro-

gens is not noted .
An understanding of the actions of hormones has led
to the most recent treatment of prostatic malignancies.
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In a series of human cases, Huggins found a 50 percent
decrease in the size of the prostate in three months-a decrease of androgenic hormones being the specific effect of cast r ation .

Regression of th e sites of metastatic

growth was also noted by X- ray .

Testosterone pro p rion ut e

when injected b rought on an aggrevation of symptoms and
increased urine phosphotase in three weeks'

.

time .

In

turn, when this process was discontinued, a marked im-

I

provement of the patients was noted .
The interrelations of hormone s is a lso noted when
the andr o gen s are discussed , just as they have been a
prominent feature of all endocrine secretions .

Failu~e

o f clinical improvement when castration has be en

per-

formed may well be blamed upon the adrenal glands, for
they too produce androgens .
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SUMMARY AND CONCLUSIONS

38

This paper has considered the endocrine secretions

and their effect on malignant tumor growth.

An

attempt

has been made to consider only the secretions and their
effects without consideration of other factors which in
fluence in incidence and rate of cancer growth.
exclusion has in

Such an

part failed, for tancer growth depends

u pon a number of factors--this fact alone is found preve
lent throughout the material examined by this author.
Malignant tumors of the uterus, mamma, and prostate
are apparently chiefly produced, or greatly influenced,
by endocrine secretions.

Interesting to note is the high

incidence of such tumors in humans, and the constant ef
fect of the sex hormones in experimental animals.
In general it may be stated that the work presented
shovs that the endocrine secretions effect the incidence
rate, and prevention of malignant tumor growth in ex
perimental animals.

But such a statement may be consid

ered valid only when heredity (or predisposition) and the
hormonal' interrelations are considered.

Let it be rep

resented in another light--isolated secretions as the
pituitary or definite sex hormones when offered to ex
perimental animals effects the rate, incidence, or pre
vention of ,a.�lignant growth.
true process in man?

Can this be considered the

Certainly gross hormonal perver-
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sions in man do not so effect malignant growth.

The

effect then must be concerned with variable factors.
William Cramer best presents this viewpoint.

The hor

mones influence malignant tumor growth as being one vari
able factor, another being susceptibility, while the third
is time relationship.

The carcinogenic agent, the hor

mones, may be increas�d or diminished, while the other
variable factors are.inversely represented.

A weak agent

over a long duration of time, or in a highly susceptible
individual may produce. cancer. The "cancer age" takes
on more importance by this viewpoint.
\
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